Baxter Qiaoguang Healthcare To Set Up Parenteral Nutrition Plant In Guangzhou
This article was originally published in PharmAsia News
Executive Summary
Baxter Qiaoguang Healthcare (Guangzhou), a 50-50 joint venture between Guangzhou Baiyunshan Pharmaceutical and Baxter, has announced that it will invest more than 300 million yuan (43.46 million) to set up new facilities to produce world-class parenteral nutrition products in Guangzhou Economic and Technological Development Zone. The new plant will start operating by the end of 2010, with an annual output and value of 20 million packs and $200 million, respectively. Baxter China notes that China is the world's fourth biggest parenteral nutrition market at $233 million and growing at 10 percent year on year; it will be one of the company's three most important markets globally. (Click here for more - Chinese Language)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.